No invented duty
The instrument governs the Minister, and the standards are met through accreditation.
Section 3 of F2026L00927 states the authority: subsection 23DNA(1) of the Health Insurance Act 1973. That power lets the Minister determine the principles applied in exercising the approval powers under section 23DN. The instrument is therefore part of the machinery by which the Minister approves, refuses, varies or revokes an approval of premises as an accredited pathology laboratory. It does not, by itself, command a laboratory to do anything.
| Party | What it carries | Source |
|---|---|---|
| The Minister | Applies the Principles when deciding an application or exercising a variation or revocation power. The high-confidence test and the procedural bars are on the Minister. | Health Insurance Act 1973 s 23DN; 2017 Principles ss 6 to 12 |
| Services Australia | Administers the application process. The Explanatory Statement records that the consequential amendments reflect the streamlined process it runs. | Explanatory Statement, Consequential amendments |
| The independent body (NATA) | Assesses conformity with the accreditation standards and provides the assessment report and accreditation action that the Minister weighs. | 2017 Principles ss 5, 7, 9 and 11 |
| The approved pathology authority | Operates the laboratory and holds the approval for the premises. The authority is the applicant and the party answerable for the operation. | 2017 Principles ss 5 and 11; Health Insurance Act 1973 |
| The approved pathology practitioner | Renders the pathology services. Medicare benefits depend on the service being rendered by or on behalf of an approved practitioner in an accredited laboratory operated by an approved authority. | Explanatory Statement, Background |
| The laboratory quality and accreditation lead | Prepares the evidence the assessor samples, maintains the document register and keeps the standards current. The duty is practical, through the accreditation and the approval, not a direct statutory command in this instrument. | 2017 Principles Sch 1; this record |
| A health insurer or reinsurer | No direct duty under this instrument. Its leverage is the provider contract and the claims consequence of an accreditation lapse. | This record; the instrument text is silent on insurers |
| A software vendor | No direct duty under this instrument. The laboratory's in-house IVD obligations from 1 July 2027 reach software it develops or uses, and the vendor's conformance evidence is what the laboratory will ask for. | Explanatory Statement, 2026 In-house IVD Standard |
Why the distinction matters
A board paper that says "the Commonwealth now requires our laboratory to..." is likely to be wrong on the legal route, even where the practical requirement is real. The accurate sentence is that the approval depends on a high-confidence assessment against the standards, and the standards were changed on the dates in the instrument. That sentence survives a legal review and still tells the board what to fund.
What the insurer can do
- Check that the provider contract warrants accreditation against the standards in force, not a named edition that may be out of date.
- Require notification of a material change to accreditation, including a suspension, a condition or a revocation.
- Ask for the current assessment report summary and the scope, not the certificate alone.
- Know which services would lose Medicare eligibility if the approval lapsed, and what that means for claims.
Not legal advice; does not certify. This page describes the chain the text establishes and does not assert a duty the text does not create.